Scientists have found an experimental small molecule that induces a form of cell death to kill a variety of cancers while enhancing the power of the immune system and leaving healthy cells totally unscathed.
Immunotherapy treatments have proven wildly successful in treating some patients with cancer. But despite this success, the majority of patients do not respond to the treatments.
Oct 26, 2015
1
67
Many plants contain bioactive ingredients that can alleviate human diseases. These phytocompounds often contain restorative biological properties such as anti-cancerous, antioxidant and anti-inflammatory effects. Thus, understanding ...
Sep 24, 2020
1
31
To the amazement of researchers in immunology and genetics, a previously unsuspected mechanism is activated in the presence of pathogens after only a few hours. "In the hours following an attack by bacteria, we observed the ...
Jan 12, 2016
0
74
For the first time, a research team at Lund University in Sweden has successfully reprogrammed mouse and human skin cells into immune cells called dendritic cells. The process is quick and effective, representing a pioneering ...
Dec 10, 2018
0
262
A phase one study of 11 patients with glioblastoma who received injections of an investigational vaccine therapy and an approved chemotherapy showed the combination to be well tolerated while also resulting in unexpectedly ...
Apr 14, 2017
2
280
One of the mysteries of lupus is why the immune cells that normally keep inflammation at bay can't seem to do their job. A University College London study published on March 8 in Immunity now suggests that for people with ...
Mar 8, 2016
0
296
Using a precursor to dendritic cells appears to be an efficient and effective way to stimulate the immune system to fight cancer tumors, according to a study in animal and cell models by researchers at the Duke Cancer Institute.
Nov 14, 2019
0
405
In vaccination, a certain subpopulation of dendritic cells is vital to triggering the body's adaptive immune system, report researchers at The Jackson Laboratory (JAX), Yale University and Astra-Zeneca.
Dec 1, 2017
1
180
Researchers at Boston Children's Hospital have identified, for the first time, the molecule that enables immune cells to release interleukin-1 (IL-1), a key part of our innate immune response to infections. Findings were ...
Nov 28, 2017
0
264
